Projects per year
Personal profile
Personal Statement
Chancellor's Research Fellow and Lecturer in Translational Pharmaceutics
My background is in drug development, where I have contributed to a diverse molecule portfolio to date during my time at AstraZeneca and working with Patrys Ltd at the Yale School of Medicine. I am interested in the characterization of biologics and nanomedicine formulation attributes and in vivo performance using traditional and novel analytical approaches. This is to overcome the key challenges in the commercial and clinical translation of these products.
Areas of research interest in my lab are summarized as follows;
- Understanding environmental and physicochemical determinants of solution-phase formulation stability for antibody and suspension formulations.
- Determining key critical quality attributes in particle design to inform optimal in vivo performance.
- Evaluation of nanomedicine interaction with biological media, and the mechanism of cellular uptake in two- and three-dimensional cellular models.
- Applying novel imaging modalities for evaluating drug and nanoparticle biodistribution, and impact on tumor response.
- The interplay between the tumour microenvironment and nanomedicine in vivo performance with a view to developing biorelevant in vitro tests.
My lab is also interested in understanding the biological drivers of disease in lupus and oncology with a view to developing new diagnostics and therapeutics.
I am passionate about improving access to education, achievement and realizing potential for young budding scientists and am open to local STEM and healthcare-related widening participation initiatives. I am co-director (Pharmacy) with Dr Margaret Cunningham (Biomedical Sciences) for outreach in the Strathclyde Institute of Pharmacy & Biomedical Sciences.
Education/Academic qualification
Master of Pharmacy, University of Manchester
Sep 2004 → May 2008
Award Date: 8 Jul 2008
Doctor of Philosophy
Sep 2009 → May 2013
Keywords
- Drug Delivery
- Drug development
- Protein aggregation
- Nanoparticles
- Cancer therapy
Fingerprint
- 4 Similar Profiles
Network
Projects
-
-
Doctoral Training Partnership 2018-19 University of Strathclyde | Daramy, Karim
Rattray, Z., Perrie, Y. & Daramy, K.
EPSRC (Engineering and Physical Sciences Research Council)
1/10/20 → 1/04/24
Project: Research Studentship - Internally Allocated
Research Output
-
Sex differences in colon cancer metabolism reveal a novel subphenotype
Cai, Y., Rattray, N. J. W., Zhang, Q., Mironova, V., Santos-Neto, A., Hsu, K-S., Rattray, Z., Cross, J. R., Zhang, Y., Paty, P. B., Khan, S. A. & Johnson, C. H., 17 Mar 2020, In: Scientific Reports. 10, 13 p., 4905.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)2 Downloads (Pure) -
Metabolic dysregulation in vitamin E and carnitine shuttle energy mechanisms associate with human frailty
Rattray, N. J. W., Trivedi, D. K., Xu, Y., Chandola, T., Johnson, C. H., Marshall, A. D., Mekli, K., Rattray, Z., Tampubolon, G., Vanhoutte, B., White, I. R., Wu, F. C. W., Pendleton, N., Nazroo, J. & Goodacre, R., 5 Nov 2019, In: Nature Communications. 10, 1, 12 p., 5027.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Citations (Scopus)15 Downloads (Pure)
Prizes
-
AstraZeneca innovation award winner
Rattray, Zahra (Recipient), Aug 2008
Prize: Prize (including medals and awards)
-
Award for best grade in physical pharmacy
Rattray, Zahra (Recipient), Sep 2005
Prize: Prize (including medals and awards)
Activities
-
External Examiner
Zahra Rattray (Examiner)
1 Dec 2020 → 1 Dec 2024Activity: Examination types › Examination
-
CELL & GENE THERAPY:from concept to medicinal use
Zahra Rattray (Organiser)
14 May 2020Activity: Participating in or organising an event types › Participation in conference